Search by Drug Name or NDC
NDC 00006-3075-02 PREVYMIS 240 mg/1 Details
PREVYMIS 240 mg/1
PREVYMIS is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is LETERMOVIR.
MedlinePlus Drug Summary
Letermovir is used to help prevent cytomegalovirus (CMV) infection and disease in certain people who have received a hematopoietic stem-cell transplant (HSCT; a procedure that replaces diseased bone marrow with healthy bone marrow) and are at increased risk of developing a CMV infection. Letermovir is in a class of medications called antivirals. It works by slowing the growth of CMV.
Related Packages: 00006-3075-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Letermovir
Product Information
| NDC | 00006-3075 |
|---|---|
| Product ID | 0006-3075_21e739f3-f406-4bfe-8363-b8ee526a0a5e |
| Associated GPIs | 12200045000320 |
| GCN Sequence Number | 077898 |
| GCN Sequence Number Description | letermovir TABLET 240 MG ORAL |
| HIC3 | W5A |
| HIC3 Description | ANTIVIRALS, GENERAL |
| GCN | 44049 |
| HICL Sequence Number | 044622 |
| HICL Sequence Number Description | LETERMOVIR |
| Brand/Generic | Brand |
| Proprietary Name | PREVYMIS |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | LETERMOVIR |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 240 |
| Active Ingredient Units | mg/1 |
| Substance Name | LETERMOVIR |
| Labeler Name | Merck Sharp & Dohme LLC |
| Pharmaceutical Class | Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anio |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA209939 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00006-3075-02 (00006307502)
| NDC Package Code | 0006-3075-02 |
|---|---|
| Billing NDC | 00006307502 |
| Package | 4 DOSE PACK in 1 CARTON (0006-3075-02) / 7 TABLET, FILM COATED in 1 DOSE PACK (0006-3075-01) |
| Marketing Start Date | 2017-11-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |